Creative Medical Technology Holdings(CELZ)
Focus: Creative Medical Technology Holdings is a publicly traded stem cell biotech focused on cell therapy treatments, headquartered in Phoenix, AZ and founded in 2023. The company is pre-revenue with minimal commercial traction and early-stage pipeline programs in chronic pain and diabetes.
Profile data last refreshed 11h ago · AI intelligence enriched 3w ago
Funding Stage
PUBLIC
Open Jobs
0
About Creative Medical Technology Holdings
AI assessmentNot HiringNo open roles listed right now. Follow Creative Medical Technology Holdings to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Creative Medical Technology Holdings's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
4 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Revenue
$11K
FY2025
Pipeline & Clinical Trials
CELZ-201-DDT
Chronic Back PainClinical Trials (1)
NCT07137559CELZ-201-DDT for the Treatment of Chronic Lower Back Pain
N/AHelp build intelligence for Creative Medical Technology Holdings
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.